RT Journal Article
SR Electronic
T1 A surgeon's guide to anticoagulant and antiplatelet medications part one: warfarin and new direct oral anticoagulant medications
JF Trauma Surgery & Acute Care Open
FD BMJ Publishing Group Ltd
SP e000020
DO 10.1136/tsaco-2016-000020
VO 1
IS 1
A1 Paul B McBeth
A1 Jordan A Weinberg
A1 Babak Sarani
A1 Louise Y Y Yeung
A1 Addison K May
YR 2016
UL http://tsaco.bmj.com/content/1/1/e000020.abstract
AB An increasing number of potent antiplatelet and anticoagulant medications are being used for the long-term management of cardiac, cerebrovascular, and peripheral vascular conditions. Management of these medications in the perioperative and peri-injury settings can be challenging for surgeons, mandating an understanding of these agents and the risks and benefits of various management strategies. In this two-part review, agents commonly encounter by surgeons in the perioperative and peri-injury settings are discussed and management strategies for patients on long-term antiplatelet and anticoagulant therapy reviewed. In part I, we review warfarin and the new direct oral anticoagulants. In part II, we review antiplatelet agents and assessment of platelet function and the perioperative management of long-term anticoagulant and antiplatelet therapy.